Cytology and Genetics is an esteemed academic journal published by PLEIADES PUBLISHING INC, dedicated to advancing research within the fields of cytology, cellular biology, and genetics. Since its inception in 1978, the journal has served as a platform for disseminating innovative findings and methodologies pertinent to contemporary biological sciences. With an ISSN of 0095-4527 and an E-ISSN of 1934-9440, Cytology and Genetics offers critical insights that significantly contribute to the current understanding of genetic mechanisms and cellular processes. Despite its present positioning in the Q4 quartile across multiple categories, including Agricultural and Biological Sciences and Cell Biology, the journal remains a crucial resource for emerging researchers seeking to explore complex genetic and cytogenetic landscapes. With an emphasis on empirical studies and comprehensive reviews, the journal aims to bridge gaps in knowledge and foster collaboration among scholars in the United States and beyond. As a vital tool for students, professionals, and researchers, Cytology and Genetics invites contributions that reflect the future of genetics and cytological science.

The Journal of Bronchology & Interventional Pulmonology, published by Lippincott Williams & Wilkins, is a vital periodical in the field of pulmonary and respiratory medicine, aiming to disseminate cutting-edge research, reviews, and clinical insights related to bronchial diseases and interventions. With an ISSN of 1944-6586 and E-ISSN 1948-8270, this journal has carved out a significant niche since its inception in 2009, continuing to publish innovative studies through 2024. Notably, it holds a respectable Q3 ranking in both the Medicine (miscellaneous) and Pulmonary & Respiratory Medicine categories as of 2023, indicating its growing influence in the academic community. Researchers and professionals worldwide benefit from the latest discoveries and clinical practices, enhancing their contributions to this essential area of healthcare. While the journal is not an open-access platform, its reputable standing and targeted content ensure that it remains a key resource for those dedicated to advancing knowledge in respiratory medicine. The journal’s address is located in Philadelphia, PA, further establishing it as a hub for medical research and innovation.

BMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.

The Journal of Hematopathology, published by SPRINGER HEIDELBERG, serves as a vital resource in the fields of hematology, histology, and pathology. Established in 2008, this peer-reviewed journal aims to foster the exchange of knowledge among researchers, clinicians, and students by publishing original articles, reviews, and case studies that contribute to the understanding of hematopathological disorders. While the journal currently ranks in the fourth quartile in various categories including hematology and histology, it positions itself as a platform for emergent research and insights, addressing the evolving landscape of blood-related diseases. Although not an open access journal, it provides crucial access to research findings for professionals looking to stay abreast of developments in pathologic diagnostics and therapeutic strategies. As it continues to grow, the journal remains committed to enhancing the knowledge base and scientific discourse in hematopathology.

CytoJournal is a leading open-access journal focused on the fields of pathology and forensic medicine, published by SCIENTIFIC SCHOLAR LLC. With its esteemed reputation, the journal has achieved a Q2 ranking in the 2023 Category Quartiles in its field, indicating its significant contribution and impact among its peers. Over its convergence from 2004 to 2024, CytoJournal has established itself as a pivotal platform for researchers, professionals, and students to disseminate and exchange pioneering research findings related to cytopathology and diagnostic techniques. With an emerging Scopus rank of #115 out of 208 in the field, the journal maintains a solid percentile ranking of 44th, underlining its importance in the scientific community. CytoJournal's commitment to facilitating open access ensures that critical insights and advancements in pathology and forensic medicine are easily accessible to those at the forefront of this essential area of study.

DIAGNOSTIC CYTOPATHOLOGY is a scholarly journal dedicated to advancing the field of cytopathology through the publication of high-quality research and reviews. Founded in 1985 and published by Wiley, this journal provides vital insights into the diagnosis and management of diseases through cytological techniques. With a strong presence in the academic community, it currently holds a Q3 ranking in the fields of Histology, Medicine (miscellaneous), and Pathology and Forensic Medicine, reflecting its commitment to fostering knowledge and innovation in these areas. Researchers and clinicians alike can benefit from its comprehensive articles that delve into cutting-edge methodologies and diagnostic strategies. Although not an Open Access journal, DIAGNOSTIC CYTOPATHOLOGY remains a crucial resource for professionals seeking to enhance their understanding and practice in the diagnostic realm. With an ISSN of 8755-1039 and an E-ISSN of 1097-0339, the journal continues to publish impactful studies well into 2024, ensuring that essential advancements in cytopathology reach a global audience.

ACTA CYTOLOGICA is a premier journal dedicated to the field of cytology, offering a platform for researchers, professionals, and students interested in the intricate study of cellular biology and its applications in the medical domain. Published by KARGER in Switzerland, the journal has been a vital resource since its inception in 1960 and is recognized for its rigorous peer-reviewed articles. With a notable impact factor reflecting its significance—ranked in the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, and Q3 in Histology for 2023—ACTA CYTOLOGICA continues to contribute valuable insights into cytological research and its implications for clinical practice. The journal maintains an annual focus on cutting-edge studies and reviews that enhance understanding and methodological advancements in cytology. Although it does not provide open access, it remains an essential read for those involved in histology and pathology, promising to keep them abreast of the latest findings and technological innovations in the field.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

The Annals of Clinical Biochemistry, published by SAGE Publications Inc, is a prestigious journal that has been pivotal in advancing the field of clinical biochemistry since its inception. With an ISSN of 0004-5632 and an E-ISSN of 1758-1001, this journal provides a platform for high-quality, peer-reviewed research articles, reviews, and case studies that cover a wide range of topics, including biochemical analysis, diagnostic methodologies, and the latest advancements in clinical practices. As a recognized leader in the field, it holds a Q2 ranking in both Clinical Biochemistry and Miscellaneous Medicine categories, showcasing its contribution to the evolving landscape of medical science. The journal’s impact is further underscored by its strategic emphasis on fostering collaboration between researchers and healthcare professionals. Although it does not provide Open Access options, the accessible subscription model ensures that vital research remains within reach of academic and clinical institutions. The Annals of Clinical Biochemistry aims to promote the understanding and application of biochemical techniques in clinical settings, ensuring it remains an essential resource for researchers, professionals, and students alike.

CYTOMETRY PART B-CLINICAL CYTOMETRY, published by Wiley, is a premier journal dedicated to advancing the field of cytometry with a specific focus on its clinical applications. With an impact factor reflective of its influential role in the scientific community, this journal serves as an essential resource for researchers, professionals, and students keen on exploring the latest developments in pathology, histology, and cell biology. The journal holds impressive rankings—Q1 in Pathology and Forensic Medicine and Q2 in Histology—illustrating its critical standing within the academic landscape. Covering a wide array of topics from clinical techniques to innovative applications in cytometry, it aims to disseminate high-quality research findings that contribute to enhanced diagnostic and therapeutic strategies. As an Open Access journal, it ensures that its valuable content reaches a broader audience, facilitating knowledge-sharing and fostering collaborations across interdisciplinary fields. Since its inception in 2002, CYTOMETRY PART B continues to shape the future of clinical cytometry, making significant contributions to both academia and clinical practice.